IGNOTA LABS

Ignota Labs is an innovative biotechnology company that specialises in the application of explainable AI to tackle challenging drug discovery safety endpoints.  Ignota Labs focuses on rescuing assets halted due to toxicity issues, identifying the exact safety issue mechanism, and recommending how to fix the issue while maintaining therapeutic effects. Its platform SAFEPATH accelerates the development of safe and effective therapeutics, integrating state-of-the-art computational methods with biological research to tackle significant unmet medical needs. Ignota Labs is led by an interdisciplinary executive team from AstraZeneca, The University of Cambridge and INSEAD Business School.